P/E ratio for CONMED (CNMD)

P/E ratio history for CONMED from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Boston Scientific BSX	109	195.98%	🇺🇸 USA
Smith & Nephew SNN	22.0	-40.21%	🇬🇧 UK
Teleflex TFX	20.7	-43.73%	🇺🇸 USA
Medtronic MDT	29.8	-19.07%	🇮🇪 Ireland
Integra LifeSciences IART	18.1	-50.81%	🇺🇸 USA
Stryker Corporation SYK	53.3	44.78%	🇺🇸 USA
Johnson & Johnson JNJ	10.3	-72.12%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.